A Decoupled Automation Platform for Hydrogen/Deuterium Exchange Mass Spectrometry Experiments.


Journal

Journal of the American Society for Mass Spectrometry
ISSN: 1879-1123
Titre abrégé: J Am Soc Mass Spectrom
Pays: United States
ID NLM: 9010412

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 10 06 2019
accepted: 21 08 2019
revised: 19 08 2019
pubmed: 15 11 2019
medline: 1 5 2020
entrez: 15 11 2019
Statut: ppublish

Résumé

Hydrogen/deuterium exchange mass spectrometry (HDX-MS) is a biophysical technique well suited to the characterization of protein dynamics and protein-ligand interactions. In order to accurately define the rate of exchange, HDX experiments require the repeated measure of deuterium incorporation into the target protein across a range of time points. Accordingly, the HDX-MS experiment is well suited to automation, and a number of automated systems for HDX-MS have been developed. The most widely utilized platforms all operate an integrated design, where robotic liquid handling is interfaced directly with a mass spectrometer. With integrated designs, the exchange samples are prepared and injected into the LC-MS following a "real-time" serial workflow. Here we describe a new HDX-MS platform that is comprised of two complementary pieces of automation that disconnect the sample preparation from the LC-MS analysis. For preparation, a plate-based automation system is used to prepare samples in parallel, followed by immediate freezing and storage. A second piece of automation has been constructed to perform the thawing and LC-MS analysis of frozen samples in a serial mode and has been optimized to maximize the duty cycle of the mass spectrometer. The decoupled configuration described here reduces experiment time, significantly improves capacity, and improves the flexibility of the platform when compared with a fully integrated system.

Identifiants

pubmed: 31724102
doi: 10.1007/s13361-019-02331-2
pii: 10.1007/s13361-019-02331-2
doi:

Substances chimiques

Ligands 0
Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2580-2583

Références

Nat Struct Mol Biol. 2011 May;18(5):556-63
pubmed: 21478866
J Am Soc Mass Spectrom. 2012 Sep;23(9):1512-21
pubmed: 22692830
Drug Discov Today. 2016 Mar;21(3):491-8
pubmed: 26826422
Anal Chim Acta. 2012 Apr 6;721:7-21
pubmed: 22405295
Anal Chem. 2019 Jun 4;91(11):7336-7345
pubmed: 31045344
Biochemistry. 2009 Oct 13;48(40):9668-76
pubmed: 19739677
J Med Chem. 2016 Mar 10;59(5):2255-60
pubmed: 26854023
ACS Med Chem Lett. 2012 Mar 8;3(3):207-210
pubmed: 22582136
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3459-63
pubmed: 24974344
BMC Bioinformatics. 2007 May 16;8:156
pubmed: 17506883
Anal Chem. 2016 Jun 21;88(12):6607-14
pubmed: 27224086
Structure. 2010 Oct 13;18(10):1332-41
pubmed: 20947021
Expert Rev Proteomics. 2011 Feb;8(1):43-59
pubmed: 21329427
Mass Spectrom Rev. 2006 Jan-Feb;25(1):158-70
pubmed: 16208684
Structure. 2011 Oct 12;19(10):1424-32
pubmed: 21889352
J Am Soc Mass Spectrom. 2006 Nov;17(11):1481-1489
pubmed: 16876429
J Am Soc Mass Spectrom. 2009 Apr;20(4):601-10
pubmed: 19135386
Proc Natl Acad Sci U S A. 2008 May 20;105(20):7171-6
pubmed: 18474858
Anal Chem. 2006 Feb 15;78(4):1005-14
pubmed: 16478090

Auteurs

Alfonso Espada (A)

Centro de Investigación Lilly, SA, Avenida de la Industria 30, 28108, Alcobendas, Spain.

Ruben Haro (R)

Centro de Investigación Lilly, SA, Avenida de la Industria 30, 28108, Alcobendas, Spain.

Jesus Castañon (J)

Centro de Investigación Lilly, SA, Avenida de la Industria 30, 28108, Alcobendas, Spain.

Cristina Sayago (C)

Centro de Investigación Lilly, SA, Avenida de la Industria 30, 28108, Alcobendas, Spain.

Francisco Perez-Cozar (F)

Centro de Investigación Lilly, SA, Avenida de la Industria 30, 28108, Alcobendas, Spain.

Leticia Cano (L)

Centro de Investigación Lilly, SA, Avenida de la Industria 30, 28108, Alcobendas, Spain.

Pablo Redero (P)

Centro de Investigación Lilly, SA, Avenida de la Industria 30, 28108, Alcobendas, Spain.

Manuel Molina-Martin (M)

Centro de Investigación Lilly, SA, Avenida de la Industria 30, 28108, Alcobendas, Spain.

Howard Broughton (H)

Centro de Investigación Lilly, SA, Avenida de la Industria 30, 28108, Alcobendas, Spain.

Ryan E Stites (RE)

Eli Lilly and Company, Lilly Corporate Center, Lilly Research Laboratories, Indianapolis, IN, 46285, USA.

Bruce D Pascal (BD)

Omics Informatics LLC, 1050 Bishop Street #517, Honolulu, HI, 96813, USA.

Patrick R Griffin (PR)

Department of Molecular Medicine, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL, 33458, USA.

Jeffrey A Dodge (JA)

Eli Lilly and Company, Lilly Corporate Center, Lilly Research Laboratories, Indianapolis, IN, 46285, USA.

Michael J Chalmers (MJ)

Eli Lilly and Company, Lilly Corporate Center, Lilly Research Laboratories, Indianapolis, IN, 46285, USA. chalmers_michael@lilly.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH